In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1121-1125

  Narcisi, E M ^a   Secor, W E ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FURAZOLIDONE; METRONIDAZOLE; TINIDAZOLE;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFICACY; GIARDIASIS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

EID: 0029880026     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1121     Document Type: Article

References (55)

1. Artem'ev, C. A., P. Potapnev, and A. Voskresenskaia. 1966 Furazolidon v terapii trikhopmoniaza u muzhchin. Sov. Med. 29:128-130.
2. Cates, W., M. R. Joesoef, and M. B. Goldman. 1993. Atypical pelvic inflammatory disease: can we identify clinical predictors? Am. J Obstet. Gynecol. 169:341-346.
3. Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. Morbid Mortal. Weekly Rep. 42:70-72.
4. Cotch, M. F. 1990. Vaginal infections and prematurity study group. Carriage of Trichomonas vaginalis (Tv) is associated with adverse pregnancy outcome, abstr 681. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Diamond, L. S. 1957. The establishment of various trichomonads of animals and man in axenic cultures. J. Parasitol. 43:488-490.
6. Dombrowski, M. P., R. J. Sokol, W. J. Brown, and R. A. Bronsteen. 1987. Intravenous therapy of metronidazole-resistant Trichomonas vaginalis. Obstet. Gynecol. 69:524-525
7. Forsgren, A., and L. Forssman. 1979. Metronidazole-resistant Trichomonas vaginalis Br. J. Vener. Dis. 55:351-353.
8. Fowler, K. B., and R. F. Pass. 1991. Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection. J. Infect. Dis. 164: 259-264
9. Gram, I., M. Macaluso, J. Churchill, and H. Stalsberg. 1992. Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III Cancer Causes Control 3:231-236.
10. Grodstein, F., M. B. Goldman, and D. W. Cramer. 1993. Relation of tubal infertility to history of sexually transmitted diseases. Am. J. Epidemiol 137:577-584.
11. Grossman, J. H., and R. P. Galask. 1990. Persistent vaginitis caused by metronidazole-resistant trichomonas. Obstet. Gynecol. 76:521-522
12. Guseinov, A. G., K. M. Rzakulieva, and I. S. Karaev. 1964 The treatment of trichomonal colpitis. TR Nauch-Issled Inst Okhrany Materin Detstva Azerbaidzh SSR 5:104-105.
13. Hamed, K. A., and A. E. Studemeister. 1992 Successful response of metronidazole-resistant trichomonal vaginitis to tinidazole Sex. Transm. Dis. 19:339-340.
14. Heine, P., and J. A. McGregor. 1993. Trichomonas vaginalis: a reemerging pathogen. Clin Obstet. Gynecol. 36:137-144.
15. Heyworth, R., D. Simpson, G. J. C. McNeillage, D. H. H. Robertson, and H. Young. 1980. Isolation of Trichomonas vaginalis resistant to metronidazole. Lancet ii:476-478
16. Honigberg, B. M., V. K. Farris, and M. C. Livingston. 1965. Preservation of Trichomonas vaginalis and Trichomonas gallinae in liquid nitrogen In Progress in Protozoology Proceeding 2nd International Conference Protozoology, London 1965. Excerpta Med Found. Amsterdam Int. Congr. Ser No. 91:199-200
17. Johnson, P. J. 1993. Metronidazole and drug resistance. Parasitol. Today 9:183-186.
18. Kanwar, A. J., R. Sharma, M. Rajagopalan, and S. Kaur. 1990. Fixed drug eruption due to timdazole with cross-reactivity with metronidazole. Dermatologica 180:277.
19. Kharsany, A. B. M., A. A. Hoosen, J. Moodley, J. Bagaratee, and E. Gouws. 1993 The association between sexually transmitted pathogens and cervical intra-epithelial neoplasia in a developing community. Genitourin. Med. 69: 357-360.
20. Klyszejko, C. 1964. Summing up evaluation of drugs applied in vaginal trichomonadosis of women. Wiad. Parazytol 10:255-258.
21. Kulda, J., M. Vojtechovska, J. Tachezy, P. Demes, and E. Kunzova. 1982. Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis. A case report Br J. Vener. Dis. 58:394-399.
22. Laga, M., A. Manoka, M. Kivuvu, B. Malele, M. Tuliza, N. Nzola, J. Goeman, F. Behets, V. Batter, M. Alary, W. L. Heyward, R. W. Ryder, and P. Piot. 1993 Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study AIDS 7:95-102.
23. Legal, H. P. 1974. The treatment of trichomonas and candida vaginitis with clotrimazole vaginal tablets. Postgrad. Med. J. 50:S81.
24. Lindmark, D. G., and M. Müller. 1976. Antimicrobial action, mutagenicity, and reduction of metronidazole and other nitromimidazoles. Antimicrob. Agents Chemother. 10:476-482.
25. Lohmeyer, H. 1974. Treatment of candidiasis and trichomoniasis of the female genital tract. Postgrad. Med. J. 50:S78
26. Lossick, J., S. Krajden, and D. Lambourne. 1991. Clinical outcomes substantiate in vitro tinidazole susceptibility in metronidazole resistant Trichomonas vaginalis isolates, abstr. C-147, p. 366. In Program and abstracts of the 91st General Meeting of the American Society for Microbiology 1991. American Society for Microbiology, Washington, D.C.
27. Lossick, J. G. 1986 Chemotherapy of nitroimidazole resistant vaginal trichomoniasis. Acta Univ. Carol. Biol. 30:533-545.
28. Lossick, J. G. 1989 Therapy of urogenital trichomoniasis, p 324-341. In B. M. Honigberg (ed.), Trichomonads parasitic in man. Springer Verlag, New York
29. Lossick, J. G., M. Müller, and T. E. Gorrell. 1986. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J. Infect. Dis. 153:948-955
30. McFadzean, J. A., I. M. Pugh, S. L. Squires, and J. P. F. Whelan. 1969. Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole. Br J Vener. Dis. 45:161-162.
31. Meingassner, J. G., and H. Mieth. 1976. Cross resistance of trichomonads to 5-nitroimidazole derivatives. Experientia 32:183-184.
32. Meingassner, J. G., and J. Thurner. 1979. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles Antimicrob. Agents Chemother 15:254-257.
33. Minkoff, H., A. N. Grunebaum, R. H. Schwarz, J. Feldman, M. Cummings, W. Crombleholme, L. Clark, G. Pringle, and W. M. McCormack. 1984. Risk factors for prematurity and premature rupture of membranes, a prospective study of the vaginal flora in pregnancy. Am. J. Obstet. Gynecol. 150:965-972.
34. Mishra, D., M. Mobashir, and M. S. Zaheer. 1990. Fixed drug eruption and cross-reactivity between tinidazole and metronidazole. Int. J. Dermatol. 29: 740.
35. Moreno, S. N., R. P. Mason, R. P. Muniz, F. S. Cruz, and R. Docampo. 1983. Generation of free radicals from metronidazole and other nitroimidazoles by Tritrichomonas foetus. J. Biol. Chem. 258:4051-4054
36. Müller, M., and T. E. Gorrell. 1983 Metabolism and metronidazole uptake in Trichomonas vaginalis isolates with different metronidazole susceptibilities. Antimicrob. Agents Chemother. 24:667-673.
37. Müller, M., J. G. Lossick, and T. E. Gorrell. 1988. In vitro susceptibility of Trichomonas vaginalis and treatment outcome in vaginal trichomoniasis. Sex Transm. Dis. 15:17-24.
38. Müller, M., J. G. Meingassner, W. A. Miller, and W. J. Ledger. 1980. Three metrondiazole-resistant strains of Trichomonas vaginalis from the United States. J. Obstet. Gynecot. 13:808-812.
39. Nyirjesy, P., M. Velma Weitz, S. P. Gelone, and T. Fekete. 1995. Paromomycin for nitroimidazole-resistant trichomonas. Lancet 346:1110.
40. Quon, D. V. K., C. E. D'Oliveira, and P. J. Johnson. 1992 Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis. Proc. Natl. Acad. Sci. USA 89:4002-4006.
41. Robertson, D. H. H., R. Heyworth, C. Harrison, and W. R. H. Lumsden. 1988 Treatment failure in Trichomonas vaginalis infections in females. I. Concentrations of metronidazole in plasma and vaginal content during normal and high dosage. J. Antimicrob. Chemother. 21:373-378.
42. Robinson, S. C. 1962. Trichomonal vaginitis resistant to metronidazole. Can. Med. Assoc. J. 86:665.
43. Rogers, G. S., G. B. Belloff, M. F. Paul, J. A. Yurchenco, and G. Gever. 1956. Furazolidone, a new antimicrobial nitrofuran. Antibiot Chemother (Washington, D C.) 6:231-242.
44. Schwartz, J. 1956. Tricofuron therapy of Trichomonas vaginitis. Obstet. Gynecol. 7:312-314.
45. Sears, S. D., and J. O'Hare. 1988 In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents. Antimicrob. Agents Chemother 32:144-146.
46. Soper, D. E., R. C. Bump, and W. G. Hurt. 1990. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am. J. Obstet. Gynecol. 163:1016-1023.
47. Spitzbart, H., and I. Wilk. 1966. Paromomycin zur Behandlung der Trichomonaden-Infektion bei der Frau geeignet? II. Klinische Erfahrungen. Zentralbl. Gynaekol. 88:563-566.
48. Stern, I. J., R. D. Hollifield, S. Wilk, and J. A. Buzard. 1967. The antimonoamine oxidase effects of furazolidone. J. Pharmacol. Exp. Ther. 156: 492-499.
49. Tocher, J. H., and D. I. Edwards. 1994. Evidence for the direct interaction of reduced metronidazole derivatives with DNA bases. Biochem. Pharmacol. 48:1089-1094.
50. Valentine, C. B. 1995 Management of Trichomonas vaginalis infection in a woman with allergy to metronidazole, abstr. 216. In Program and abstracts of the Eleventh Meeting of the International Society for STD Research.
51. Voolmann, T., and P. Boreham. 1993. Metronidazole resistant Trichomonas vaginalis in Brisbane. Med J. Aust. 159:490.
52. White, A. H. 1989. Absorption, distribution, metabolism, and excretion of furazolidone. Scand. J. Gastroenterol. 24:4-10.
53. Willmott, F., J. Say, D. Downey, and A. Hookman. 1983 Zinc and recalcitrant trichomonas Lancet i:1053.
54. Wong, C. A., P. D. Wilson, and T. A. Chew. 1990. Povidone-iodine in the treatment of metronidazole-resistant Trichomonas vaginalis. Aust. N. Z. J. Obstet. Gynaecol 30:169-171.
55. Zhang, Z.-F., and C. B. Begg. 1994. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int. J. Epidemiol. 23:682-690.